UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:November 15,
Rhythm Pharmaceuticals (NASDAQ:RYTM)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Rhythm Pharmaceuticals Charts.
Rhythm Pharmaceuticals (NASDAQ:RYTM)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Rhythm Pharmaceuticals Charts.

Rhythm Pharmaceuticals, Inc. News

Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology
Tuesday 30 April 2024 (4 days ago) • GlobeNewswire Inc.
Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
Thursday 25 April 2024 (1 week ago) • GlobeNewswire Inc.
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
Wednesday 17 April 2024 (3 weeks ago) • GlobeNewswire Inc.
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
Monday 1 April 2024 (1 month ago) • GlobeNewswire Inc.
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist
Monday 25 March 2024 (1 month ago) • GlobeNewswire Inc.
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
Tuesday 12 March 2024 (2 months ago) • GlobeNewswire Inc.
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences
Thursday 7 March 2024 (2 months ago) • GlobeNewswire Inc.
Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 22 February 2024 (2 months ago) • Edgar (US Regulatory)

More Rhythm Pharmaceuticals, Inc. News Articles